M Matz

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 6.2K citations · Full text

Medicine, Biostatistics, Oncology +17

Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

Audrey Bonaventure, Rhea Harewood, Charles Stiller et al. · The Lancet Haematology · 2017 · 215 citations · Full text

Medicine, Oncology, Pediatrics +17

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

M Matz, Michel P. Coleman, Milena Sant et al. · Gynecologic Oncology · 2016 · 158 citations · Full text

Medicine, Oncology, Pathology +16

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

M Matz, Michel P. Coleman, Helena Carreira et al. · Gynecologic Oncology · 2016 · 140 citations · Full text

Medicine, Gynecology, Oncology +16

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000–2014 in 59 countries (CONCORD-3)

V Di Carlo, Charles Stiller, Nora Eisemann et al. · British Journal of Dermatology · 2022 · 131 citations · Full text

Medicine, Dermatology, Oncology +16